Bibliography
Export 30 results:
Filters: Keyword is Bone Marrow Transplantation / *adverse effects [Clear All Filters]
Evidence of donor-derived hematologic malignancies after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2006;12(5):511-7.
Pulmonary complications in bone marrow transplantation: a practical approach to diagnosis and treatment. Clin Chest Med. 2004;25(1):189-201.
Alopecia areata after allogeneic bone marrow transplantation from an affected, human leukocyte antigen-matched sibling. J Am Acad Dermatol. 2003;49(6):1192.
Donor-cell myelodysplastic syndrome developing 13 years after marrow grafting for aplastic anemia. Cancer Genet Cytogenet. 2003;142(2):124-8.
T-cell large granular lymphocyte leukemia of donor origin after allogeneic bone marrow transplantation. Am J Clin Pathol. 2003;120(4):626-30.
Acute myeloid leukaemia of donor cell origin developing 5 years after allogeneic bone marrow transplantation for chronic myeloid leukaemia. Bone Marrow Transplant. 2002;29(5):449-52.
Asthma as a consequence of bone marrow transplantation. Chest. 2002;122(1):369-70.
Leukaemic relapse of donor origin after allogeneic bone marrow transplantation from a donor who later developed bronchogenic carcinoma. Br J Haematol. 2002;119(3):777-80.
Occurrence of multiple myeloma in both donor and recipient after bone marrow transplantation. Am J Hematol. 2002;71(3):227-8.
Is type 1 diabetes transmissible by bone marrow allograft? Diabetes Care. 2002;25(4):799-800.
Changes in autoimmune thyroid disease following allogeneic bone marrow transplantation. Bone Marrow Transplant. 2001;28(1):63-6.
Transmission of a T-cell lymphoma by allogeneic bone marrow transplantation. N Engl J Med. 2001;345(20):1458-63.
Brucellosis transmitted by bone marrow transplantation. Bone Marrow Transplant. 2000;26(2):225-6.
Donor cell leukemia: report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature. Am J Hematol. 2000;63(1):46-53.
Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells. Bone Marrow Transplant. 2000;25(12):1285-7.
Hodgkin's disease of donor origin after allogeneic bone marrow transplantation for myelogeneous chronic leukemia. Transplantation. 1998;65(4):595-7.
Transfer of diabetes type 1 by bone-marrow transplantation. Lancet. 1998;351(9102):568-9.
[Positive seroconversion syphilis in a patient with acute lymphocytic leukemia after allogeneic bone marrow transplantation]. Rinsho Ketsueki. 1997;38(3):228-30.
Solid cancers after bone marrow transplantation. N Engl J Med. 1997;336(13):897-904.
Transfer of atopy following bone marrow transplantation. Ann Allergy Asthma Immunol. 1997;78(5):513-6.
Cardiac arrhythmia after infusion of cryopreserved stem cells. Bone Marrow Transplant. 1994;14(3):363-7.
Possible transmission of sarcoidosis via allogeneic bone marrow transplantation. Bone Marrow Transplant. 1994;14(1):161-4.
Diffuse alveolar hemorrhage following autologous bone marrow infusion. Bone Marrow Transplant. 1993;12(3):301-3.
Recurrence of acute leukemia in donor cells after bone marrow transplantation: documentation by in situ DNA hybridization. Bone Marrow Transplant. 1993;12(1):77-80.
Antilymphocyte globulin for treatment of pure red cell aplasia after major ABO incompatible marrow transplant. Bone Marrow Transplant. 1992;10(5):471-2.